Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Double A Dairy, LLC
WARNING LETTER
•Double A Dairy, LLC•July 24, 2015

FDA WARNING_LETTER - Double A Dairy, LLC - July 24, 2015

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Double A Dairy, LLC
Record Details

On July 22 and 24, 2015, the FDA inspected Ron Aardema and Donald Aardema, Jr.'s dairy operation in Jerome, Idaho, and found violations of the Federal Food, Drug, and Cosmetic Act.

The primary violation involved the sale of an adulterated dairy cow for slaughter on May 18, 2015. USDA/FSIS analysis of the animal's liver tissue revealed sulfadimethoxine at 0.334 ppm, exceeding the FDA tolerance of 0.1 ppm, rendering the food adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.

The investigation also found insanitary conditions, specifically a failure to maintain complete treatment records, which could lead to medicated animals with harmful drug residues entering the food supply, thus adulterating food under section 402(a)(4) of the FD&C Act.

Furthermore, the new animal drug Albon (sulfadimethoxine) was adulterated due to extralabel use. The firm administered Albon to dairy cows for pneumonia and foot rot without following approved labeling or veterinarian's orders, resulting in an illegal drug residue. This extralabel use violated 21 C.F.R. 530.11(d) and 21 C.F.R. 530.41(a)(9),

Company
Double A Dairy, LLC
Inspection Date
July 24, 2015
Product Type
Drugs
Office
Seattle District Office
People
  • Miriam R. Burbach
  • John Andersen
  • Debra M. Lawrence (Associate Professor )
Open in Dashboard

ID · b513b813-4d9a-41af-920b-0b546ab411f6

Violation Codes8
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 530.3(a)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 CFR 530.11(d)21 CFR 530.41(a)(9)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.